Part 3.7 / M18

Index No

►M18  Chemical name ◄

EC No

CAS No

Classification

Labelling

►M18  Specific Conc. Limits, M-factors and ATEs (*1)  ◄

Notes

Hazard Class and

Category Code(s)

Hazard statement Code(s)

Pictogram, Signal Word Code(s)

Hazard statement Code(s)

Suppl. Hazard statement Code(s)

▼M16

006-044-00-7

isoproturon (ISO);

3-(4-isopropylphenyl)-1,1-dimethylurea

251-835-4

34123-59-6

Carc. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H373 (blood)

H400

H410

GHS08

GHS09

Wng

H351

H373 (blood)

H410

M = 10

M = 10

015-101-00-5

phosmet (ISO);

S-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl] O,O-dimethyl phosphorodithioate;

O,O-dimethyl-S-phthalimidomethyl phosphorodithioate

211-987-4

732-11-6

Repr. 2

Acute Tox. 4

Acute Tox. 3

STOT SE 1

Aquatic Acute 1

Aquatic Chronic 1

H361f

H332

H301

H370 (nervous system)

H400

H410

GHS08

GHS06

GHS09

Dgr

H361f

H332

H301

H370 (nervous system)

H410

M = 100

M = 100

016-096-00-2

thifensulfuron-methyl (ISO);

methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate

—

79277-27-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 100

M = 100

017-011-00-1

sodium hypochlorite, solution … % Cl active

231-668-3

7681-52-9

Skin Corr. 1B

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H318

H400

H410

GHS05

GHS09

Dgr

H314

H410

EUH031

M = 10

M = 1

EUH031:

C ≥ 5 %

B

025-002-00-9

potassium permanganate

231-760-3

7722-64-7

Ox. Sol. 2

Repr. 2

Acute Tox. 4 * Aquatic Acute 1 Aquatic Chronic 1

H272

H361d

H302

H400

H410

GHS03

GHS08

GHS07

GHS09

Dgr

H272

H361d

H302

H410

603-180-00-4

colecalciferol;

cholecalciferol;

vitamin D3

200-673-2

67-97-0

Acute Tox. 2 Acute Tox. 2 Acute Tox. 2

STOT RE 1

H330

H310

H300

H372

GHS06

GHS08

Dgr

H330

H310

H300

H372

604-014-00-3

chlorocresol;

4-chloro-m-cresol;

4-chloro-3-methylphenol

200-431-6

59-50-7

Acute Tox. 4

Skin Corr. 1C

Eye Dam. 1

STOT SE 3

Skin Sens. 1B Aquatic Acute 1

Aquatic Chronic 3

H302

H314

H318

H335

H317

H400

H412

GHS07

GHS05

GHS09

Dgr

H302

H314

H335

H317

H410

M = 1

604-016-00-4

1,2-dihydroxybenzene;

pyrocatechol

204-427-5

120-80-9

Carc. 1Β

Muta. 2

Acute Tox. 3

Acute Tox. 3

Skin Irrit. 2

Eye Irrit. 2

H350

H341

H311

H301

H315

H319

GHS08

GHS06

Dgr

H350

H341

H311

H301

H315

H319

604-090-00-8

4-tert-butylphenol

202-679-0

98-54-4

Repr. 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 1

H361f

H315

H318

H410

GHS08

GHS05

GHS09

Dgr

H361f

H315

H318

H410

M = 1

604-094-00-X

isoeugenol; [1]

(E)-2-methoxy-4-(prop-1-enyl)phenol; [2]

(Z)-2-methoxy-4-(prop-1-enyl)phenol [3]

202-590-7 [1]

227-678-2 [2]

227-633-7 [3]

97-54-1 [1]

5932-68-3 [2]

5912-86-7 [3]

Skin Sens. 1A

H317

GHS07

Wng

H317

Skin Sens. 1A; H317: C ≥ 0,01 %

605-003-00-6

acetaldehyde;

ethanal

200-836-8

75-07-0

Flam. Liq. 1

Carc. 1B

Muta. 2

STOT SE 3

Eye Irrit. 2

H224

H350

H341

H335

H319

GHS02

GHS08

GHS07

Dgr

H224

H350

H341

H335

H319

607-096-00-9

maleic anhydride

203-571-6

108-31-6

Acute Tox. 4

STOT RE 1

Skin Corr. 1B

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1A

H302

H372 (respiratory system) (inhalation)

H314

H318

H334

H317

GHS07

GHS08

GHS05

Dgr

H302

H372 (respiratory system) (inhalation)

H314

H334

H317

EUH071

Skin Sens. 1A; H317: C ≥ 0,001 %

607-103-00-5

succinic anhydride

203-570-0

108-30-5

Acute Tox. 4

Skin Corr. 1

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

H302

H314

H318

H334

H317

GHS07

GHS05

GHS08

Dgr

H302

H314

H334

H317

EUH071

607-113-00-X

isobutyl methacrylate

202-613-0

97-86-9

Flam. Liq. 3

STOT SE 3

Skin Irrit. 2

Skin Sens. 1B

H226

H335

H315

H317

GHS02

GHS07

Wng

H226

H335

H315

H317

D

607-373-00-4

quizalofop-P-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate

414-200-4

200509-41-7

Carc. 2

Repr. 2

Acute Tox. 4

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H361fd

H302

H373

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361fd

H302

H373

H410

M = 1

M = 1

607-724-00-1

2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (1R,3R)-2,2-dimethyl-3-[(1Z)-prop-1-en-1-yl]cyclopropanecarboxylate; epsilon-metofluthrin

—

240494-71-7

Acute Tox. 4

Acute Tox. 3

STOT SE 1

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H332

H301

H370 (nervous system)

H373

H400

H410

GHS06

GHS08

GHS09

Dgr

H332

H301

H370 (nervous system)

H373

H410

M = 100

M = 100

607-725-00-7

isopropyl (2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca-2,4-dienoate; S-methoprene

—

65733-16-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

607-726-00-2

pinoxaden (ISO);

8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate

—

243973-20-8

Repr. 2

Acute Tox. 4

Acute Tox. 4

Eye Irrit. 2

STOT SE 3

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 3

H361d

H332

H302

H319

H335

H317

H400

H412

GHS08

GHS07

GHS09

Wng

H361d

H332

H302

H319

H335

H317

H410

607-727-00-8

tetramethrin (ISO);

(1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate

231-711-6

7696-12-0

Carc. 2

Acute Tox. 4

STOT SE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H371 (nervous system) (inhalation)

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H371 (nervous system) (inhalation)

H410

M = 100

M = 100

607-728-00-3

(1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate

214-619-0

1166-46-7

Carc. 2

Acute Tox. 4

STOT SE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H371 (nervous system) (inhalation)

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H371 (nervous system) (inhalation)

H410

M = 100

M = 100

607-729-00-9

mesosulfuron-methyl (ISO);

methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate;

—

208465-21-8

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 100

M = 100

607-730-00-4

spirodiclofen (ISO);

3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate

—

148477-71-8

Carc. 1B

Repr. 2

STOT RE 2

Skin Sens. 1B

Aquatic Chronic 1

H350

H361f

H373

H317

H410

GHS08

GHS07

GHS09

Dgr

H350

H361f

H373

H317

H410

M = 10

607-731-00-X

sodium methyl [(4-aminophenyl)sulphonyl]carbamate; sodium methyl (EZ)-sulfanilylcarbonimidate; asulam-sodium

218-953-8

2302-17-2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 1

M = 1

607-732-00-5

salicylic acid

200-712-3

69-72-7

Repr. 2

Acute Tox. 4

Eye Dam. 1

H361d

H302

H318

GHS08

GHS07

GHS05

Dgr

H361d

H302

H318

608-068-00-9

flutianil (ISO);

(2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile

—

958647-10-4

Aquatic Chronic 1

H410

GHS09

Wng

H410

M = 100

612-293-00-8

reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy)but-2-ylamine

447-920-2

—

Repr. 2

Acute Tox. 4

Skin Corr. 1B

Eye Dam. 1

H361f

H302

H314

H318

GHS08

GHS07

GHS05

Dgr

H361f

H302

H314

EUH071

613-167-00-5

reaction mass of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1)

—

55965-84-9

Acute Tox. 2

Acute Tox. 2

Acute Tox. 3

Skin Corr. 1C

Eye Dam. 1

Skin Sens. 1A Aquatic Acute 1

Aquatic Chronic 1

H330

H310

H301

H314

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H330

H310

H301

H314

H317

H410

EUH071

Skin Corr. 1C; H314: C ≥ 0,6 %

Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %

Eye Dam. 1; H318: C ≥ 0,6 %

Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %

Skin Sens. 1A; H317: C ≥ 0,0015 %

M = 100

M = 100

B

613-205-00-0

propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]methyl}-1H-1,2,4-triazole

262-104-4

60207-90-1

Repr. 1B

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H360D

H302

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H360D

H302

H317

H410

M = 1

M = 1

613-326-00-9

2-methylisothiazol-3(2H)-one

220-239-6

2682-20-4

Acute Tox. 2

Acute Tox. 3

Acute Tox. 3

Skin Corr. 1B

Eye Dam. 1

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H330

H311

H301

H314

H318

H317

H400

H410

GHS05

GHS06

GHS09

Dgr

H330

H311

H301

H314

H317

H410

EUH071

Skin Sens. 1A; H317: C ≥ 0,0015 %

M = 10

M = 1

613-327-00-4

pyroxsulam (ISO);

N-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)-2-methoxy-4-(trifluoromethyl)pyridine-3-sulfonamide

—

422556-08-9

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M = 100

M = 100

613-328-00-X

1-vinylimidazole

214-012-0

1072-63-5

Repr. 1B

H360D

GHS08

Dgr

H360D

Repr. 1B; H360D: C ≥ 0,03 %

614-001-00-4

nicotine (ISO);

3-[(2S)-1-methylpyrrolidin-2-yl]pyridine

200-193-3

54-11-5

Acute Tox. 2

Acute Tox. 2

Acute Tox. 2

Aquatic Chronic 2

H330

H310

H300

H411

GHS06

GHS09

Dgr

H330

H310

H300

H411

616-224-00-2

amisulbrom (ISO);

3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide

—

348635-87-0

Carc. 2

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H319

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H319

H410

M = 10

M = 10